Page last updated: 2024-10-29

ketoconazole and Dysmyelopoietic Syndromes

ketoconazole has been researched along with Dysmyelopoietic Syndromes in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denning, DW1
Stepan, DE1
Blume, KG1
Stevens, DA1
Engelhard, D1
Or, R1
Naparstek, E1
Leibovici, V1

Other Studies

2 other studies available for ketoconazole and Dysmyelopoietic Syndromes

ArticleYear
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
    The Journal of infection, 1992, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Female;

1992
Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
    Bone marrow transplantation, 1988, Volume: 3, Issue:5

    Topics: Adult; Bone Marrow Transplantation; Drug Tolerance; Female; Humans; Itraconazole; Ketoconazole; Myel

1988